GeekWire March 6, 2024
Taylor Soper

PreemptiveAI came out of stealth mode this week, announcing $6.4 million in seed funding that will help the Seattle startup build what it describes as the “most predictive large medical model.”

The company, incubated at the AI2 Incubator in Seattle, takes biomedical signals from smartphones and wearable devices to create AI software aimed at predicting health outcomes.

The startup aims to answer questions about the likelihood of a heart attack or stroke, and response to changes in medication dosage, for example. Potential customers include providers, drug developers, and insurance companies.

PreemptiveAI has a strategic partnership with Duke University to monitor patient data remotely and help identify health risks.

GeekWire reported on the company, then known as Measure Labs, in 2022.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Digital Health, Technology, Wearables
Artificial intelligence: Revolutionizing patient education in primary care
Four ways the vaccine rush will define infectious disease trends for CROs in 2024
Q&A: Insurance exec says AI nearly perfect when processing tens of thousands of documents
High-tech, high-touch: 4 ways nursing leaders can strike the right balance for AI-averse teams
AI for social good in sustainable development goals

Share This Article